Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Sunil Healthcare Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Sunil Healthcare Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sunil Healthcare Q1 net profit zooms 2800.00% at Rs 0.29 cr

    30 Jul 2025, 7:12PM The company reported standalone net profit of Rs 0.29 crore for the quarter ended June 30, 2025 as compared to Rs 0.01 crore in the same period last y
  • Sunil Healthcare - Board Meeting Outcome for Outcome Of Board Meeting Held On 30.07.2025

    30 Jul 2025, 6:40PM 1. Approved the Un-Audited Financial Results (both standalone and consolidated) for the 1st quarter of the Financial year 2025-26 ended on June 30, 20
  • Sunil Healthcare - Un-Audited Financial Results For The Quarter Ended 30.06.2025

    30 Jul 2025, 6:31PM Board of Directors of the Company interalia approved the un-audited financial results for the quarter ended 30.06.2025 at their Board Meeting held on
  • Sunil Healthcare - Board Meeting Intimation for Intimation Of The Board Meeting Scheduled To Be Held On 30.07.2025, Pursuant

    18 Jul 2025, 10:40AM Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 ,inter alia, to consider and
  • Sunil Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    10 Jul 2025, 4:11PM As of June 2025, 73.53% is owned by Indian Promoters and 26.47% by Public. <p align=justify> Top three Promoters holding highest number of shares of S
  • Sunil Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Jul 2025, 12:41PM Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.2025
  • Sunil Healthcare Q4 net profit zooms 525.00% at Rs 0.25 cr

    30 May 2025, 2:24PM The company reported standalone net profit of Rs 0.25 crore for the quarter ended March 31, 2025 as compared to Rs 0.04 crore in the same period last
  • Sunil Healthcare - Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015

    29 May 2025, 7:40PM Board at their meeting held on 29.05.2025 interalia approved M/s. ATCS & Associates, Company Secretaries as Secretarial Auditor of the Company for a t
  • Sunil Healthcare - Board Meeting Outcome for Outcome Of The 263Rd Board Meeting Held On 29.05.2025

    29 May 2025, 7:23PM Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we are pleased to inform, inter-alia the outcome of the Meeting of the Board of Direct
  • Sunil Healthcare - Financial Results For The Quarter/Year Ended 31.03.2025

    29 May 2025, 7:19PM Board at their meeting held on 29.05.2025 interalia approved audited standalone and consolidated financial results for the quarter/year ended 31.03.20
  • Sunil Healthcare - Board Meeting Intimation for Intimation Of The Board Meeting Scheduled To Be Held On 29.05.2025 Pursuant

    19 May 2025, 3:14PM Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and

Key fundamentals

Evaluate the intrinsic value of Sunil Healthcare Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 140.1949 96.9397 89.0123 91.9795 92.1293
Liabilities 140.1949 96.9397 89.0123 91.9795 92.1293
Equity 10.2548 10.2548 10.2548 10.2548 10.2548
Gross Profit 4.2842 19.3069 17.8114 6.1502 -4.1147
Net Profit -2.1078 6.9769 6.7768 0.2753 -4.1662
Cash From Operating Activities -14.3492 7.1288 21.8933 16.6296 4.177
NPM(%) -2.35 6.23 5.82 0.3 -5.94
Revenue 89.6875 111.8295 116.3729 89.6311 70.1293
Expenses 85.4033 92.5226 98.5615 83.4809 74.244
ROE(%) -3.12 10.33 10.03 0.4 -6.17

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Sunil Healthcare Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 893.20 0.42 29.14 48.04 301.39 0.57
Lotus Eye Hospital and Institute Ltd 72.52 -1.89 207.11 175.04 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 22.09 -0.94 0.00 363.45 -39.50 0.00
Astec Lifesciences Ltd 890.00 -1.72 0.00 165.07 -601.21 0.00

Company Info

Sunloc, a leading brand of Empty Hard Gelatin Capsules, comes from Sunil Healthcare Ltd. Having started its operations over four decades ago, is the second largest manufacturer of EHGC in India and enjoys immense credibility in various global markets. Established in 1976 Located in Alwar (Rajasthan), 100 miles south of New Delhi, Capital of India. 2nd largest empty hard-shell gelatin (EHG) capsule producer in India. Introduced double-lock, triple lock and multi groove Capsules. Production capacity of 10.25 billion capsules/year on 22 fully automatic production lines. GMP Certificate as per NSF/IPEC/WHO-GMP/ANSI 363 Guideline & USFDA Certif¡cate - DMF No. - 18735, TYPE IV. 2014 -Sunil Healthcare Ltd shares are listed and admitted to dealings on the Exchange -Sunil Healthcare Limited (SHL) has been bestowed with the award for "Outstanding Contribution to Indias Pharmaceutical Exports during the year FY 2012-2013. 2015 -ICRA upgrades long term rating of Sunil Healthcare to BBB -Sunil Healthcare Ltd has "Award for the Best Use of Six Sigma in Healthcare by ABP News". 2016 -Sunil Healthcare sets-up wholly owned subsidiary in USA by the name of Sunil Healthcare North America LLC. 2017 -The company's Food Division has been awarded the prestigious 'Export Award' as 'Top Most Exporter under Cashew nut and Allied products from New Delhi.

Sunloc, a leading brand of Empty Hard Gelatin Capsules, comes from Sunil Healthcare Ltd. Having started its operations over four decades ago, is the second largest manufacturer of EHGC in India and enjoys immense credibility in various global markets. Established in 1976 Located in Alwar (Rajasthan), 100 miles south of New Delhi, Capital of India. 2nd largest empty hard-shell gelatin (EHG) capsule producer in India. Introduced double-lock, triple lock and multi groove Capsules. Production capacity of 10.25 billion capsules/year on 22 fully automatic production lines. GMP Certificate as per NSF/IPEC/WHO-GMP/ANSI 363 Guideline & USFDA Certif¡cate - DMF No. - 18735, TYPE IV. 2014 -Sunil Healthcare Ltd shares are listed and admitted to dealings on the Exchange -Sunil Healthcare Limited (SHL) has been bestowed with the award for "Outstanding Contribution to Indias Pharmaceutical Exports during the year FY 2012-2013. 2015 -ICRA upgrades long term rating of Sunil Healthcare to BBB -Sunil Healthcare Ltd has "Award for the Best Use of Six Sigma in Healthcare by ABP News". 2016 -Sunil Healthcare sets-up wholly owned subsidiary in USA by the name of Sunil Healthcare North America LLC. 2017 -The company's Food Division has been awarded the prestigious 'Export Award' as 'Top Most Exporter under Cashew nut and Allied products from New Delhi.

Read More

Parent Organisation

Sunil Healthcare Ltd.

Founded

05/02/1973

Managing Director

NSE Symbol

FAQ

The current price of Sunil Healthcare Ltd is

The 52-week high for Sunil Healthcare Ltd is

The market capitalization of Sunil Healthcare Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Sunil Healthcare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Sunil Healthcare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sunil Healthcare Ltd shares.

The CEO of Sunil Healthcare Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT